Selected Grants
A Phase 3, Open-Label, Multi-Center Trial to Evaluate the Long-Term Safety and Efficacy of Repeat Treatments of DaxibotulinumtoxinA for Injection in
Clinical TrialPrincipal Investigator · Awarded by Revance Therapeutics Inc. · 2019 - 2021Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Trial to Evaluate the Efficacy and Safety of a Single Treatment of DaxibotulinumtoxinA for Injection in Adults with Isolated Cervical Dystonia (ASPEN-1)
Clinical TrialPrincipal Investigator · Awarded by Revance Therapeutics Inc. · 2019 - 20213,4-Diaminopyridine In Lambert-Eaton Syndrome
ResearchCo-Principal Investigator · Awarded by Food and Drug Administration · 1994 - 19983,4,-Diaminopyridine In Lambert-Eaton Myasthenic Syndrome
ResearchCo-Principal Investigator · Awarded by Food and Drug Administration · 1994 - 19973,4-Diaminopyridine In Lambert-Eaton Myasthenic Syndrome
ResearchCo-Principal Investigator · Awarded by Food and Drug Administration · 1994 - 1997External Relationships
- Alexion
- Alexion Pharmaceuticals, Inc. a subsidiary of AstraZeneca,
- Amgen, Inc.
- Genentech
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.